Upgrade to SI Premium - Free Trial

EAGLE CAPITAL GROWTH FUND, Inc. (GRF)

10.22 -0.06 (0.58%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 4 EAGLE CAPITAL GROWTH For: Sep 01 Filed by: SIMS LUKE E September 3, 2026 4:42 PM - SEC Filing Green Rise Foods Announces Q2 Fiscal 2026 Financial Results August 31, 2026 7:21 PM - StreetInsider Form N-CSRS EAGLE CAPITAL GROWTH For: Jun 30 August 20, 2026 5:06 PM - SEC Filing Form N-PX EAGLE CAPITAL GROWTH For: Aug 20 August 20, 2026 4:25 PM - SEC Filing Grifols completes patient follow-up in phase 3 alpha-1 lung study August 10, 2026 7:01 AM - StreetInsider Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency August 10, 2026 7:00 AM - Globe NewsWire Form NPORT-P EAGLE CAPITAL GROWTH For: Jun 30 July 31, 2026 11:38 AM - SEC Filing Form 6-K Grifols SA For: Jul 30 July 30, 2026 10:49 AM - SEC Filing Grifols starts two Phase 3 trials to expand immunoglobulin labels July 16, 2026 8:01 AM - StreetInsider Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins July 16, 2026 8:00 AM - Globe NewsWire Grifols launches FESILTY fibrinogen concentrate in the US June 15, 2026 8:02 AM - StreetInsider Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S. June 15, 2026 8:00 AM - Globe NewsWire Full Article List